companydata.dkSCANPHARM A/S: Financial statements 2014
CVR: 16279099
SCANPHARM A/S (CVR 16279099) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 20,769,828 and a net result of DKK 431,209 compared with DKK 399,646 the year before. That is a decrease of 0.9% compared with the year before. Equity amounted to DKK 10,988,995. The solvency ratio was 32.6%.
- Gross Profit
- 20,769,828 kr.
- Profit/Loss
- 431,209 kr.
- Equity
- 10,988,995 kr.
- Total Assets
- 33,666,506 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 20.8 mio. | 431 t. | 11 mio. | - |
| 2013 | - | 20.9 mio. | 400 t. | 10.6 mio. | - |
Keep an eye on SCANPHARM A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2014
SCANPHARM A/S has published its annual report for 2013. Gross profit came to DKK 20,949,478, and the net result was DKK 399,646.
About SCANPHARM A/S
SCANPHARM A/S is a Danish company of the type Aktieselskab based in Birkerød, founded in 1992. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named SCANPHARM A/S AF 1992 and A/S SCANPHARM AF 1992. The management consists of Andreas Bjørn Jensen. The company is owned by CHLOPETHAN A/S and Peluli Holding ApS. The company has 51 employees. In 2025, the company reported a gross profit of DKK 29,716,677 and a net result of DKK 962,722 compared with DKK 582,684 the year before. Equity amounted to DKK 3,045,406.